論文

査読有り
2017年4月

Lipophilic triphenylphosphonium derivatives enhance radiation-induced cell killing via inhibition of mitochondrial energy metabolism in tumor cells

CANCER LETTERS
  • Hironobu Yasui
  • Kumiko Yamamoto
  • Motofumi Suzuki
  • Yuri Sakai
  • Tomoki Bo
  • Masaki Nagane
  • Eri Nishimura
  • Tohru Yamamori
  • Toshihide Yamasaki
  • Ken-ichi Yamada
  • Osamu Inanami
  • 全て表示

390
開始ページ
160
終了ページ
167
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.canlet.2017.01.006
出版者・発行元
ELSEVIER IRELAND LTD

It has recently been reported that radiation enhances mitochondrial energy metabolism in various tumor cell lines. To examine how this radiation -induced alteration in mitochondrial function influences tumor cell viability, Various lipophilic triphenylphosphonium (TPP+) cation derivatives and related compounds such as 4-hydroxy-2,2,6,6-tetramethyl-l-oxy-piperidin (Tempol) with TPP+ (named."Mito-") were designed to inhibit the mitochondrial electron transport chain. Mito-(CH2)io-Tempol (M10T) and its derivatives, Mito-(CH2)(5)-Tempol (M5T), Mito-(CH2)(10)-Tempol-Methyl (M10T-Me), Mito-C10H21 (M10), and C10H21-Tempol (10T), were prepared. In HeLa human cervical adenocarcinoma cells and A549 human lung carcinoma cells, the fractional uptake of the compound into mitochondria was highest among the TTP+ analogs conjugated with Tempol (M10T, M5T, and 10T). MlOT, M10T-Me, and M10 exhibited strong cytotoxicity and enhanced X-irradiation -induced reproductive cell death, while 10T and M5T did not. Furthermore, M10T, M10T-Me, and M10 decreased basal mitochondrial membrane potential and intracellular ATP. MIOT treatment inhibited X-ray -induced increases in ATP production. These results indicate that the TPP cation and a long hydrocarbon linker are essential for radiosensitization of tumor cells. The reduction in intracellular ATP by lipophilic TP13(+) is partly responsible for the observed radiosensitization. (C) 2017 Elsevier B.V. All rights reserved.

リンク情報
DOI
https://doi.org/10.1016/j.canlet.2017.01.006
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/28093283
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000395955700018&DestApp=WOS_CPL
ID情報
  • DOI : 10.1016/j.canlet.2017.01.006
  • ISSN : 0304-3835
  • eISSN : 1872-7980
  • PubMed ID : 28093283
  • Web of Science ID : WOS:000395955700018

エクスポート
BibTeX RIS